-
Alprazolam
Alprazolam is a benzodiazepine used to manage anxiety disorders. The abrupt withdrawal of alprazolam could result in seizure activity from central nervous system excitation. All clients receiving this medication should be warned of this danger. The other options are incorrect.
-
Oxazepam
Oxazepam causes constipation, and the client is instructed to increase fluid intake and bulk (high fiber) in the diet. If the heart begins to beat fast, the health care provider (HCP) is notified because this could indicate overdose. In addition, diarrhea could indicate an incomplete intestinal obstruction and, if this occurs, the HCP is notified.
-
Fluoxetine
The most common side and adverse effects related to fluoxetine include central nervous system and gastrointestinal system dysfunction. Fluoxetine affects the gastrointestinal system by causing nausea and vomiting, cramping, and diarrhea. Cardiovascular symptoms, dry mouth, and excessive sweating are not side and adverse effects associated with this medication.
-
Lithium- Support Pt. in long term therapy
The therapeutic serum level of lithium is 0.6 to 1.2 mEq/L, and the client's medication compliance should be acknowledged. Serum lithium concentrations of 1.5 to 2.0 mEq/L may produce a variety of toxicity symptoms, including vomiting, diarrhea, drowsiness, incoordination, coarse hand tremors, muscle tremors, and mental confusion.
-
Clozapine
The client taking clozapine may experience agranulocytosis as an adverse effect, which is monitored by obtaining weekly white blood cell counts. Treatment is withheld if the level drops below 3000 mm3 (3 × 109/L). Agranulocytosis could be fatal if undetected and untreated. The other options are incorrect.
-
A client is prescribed a monoamine oxidase inhibitor. What is the primary reason the nurse needs to assess this client closely?
Headache, hypertension, tachycardia, nausea, and vomiting are precursors to hypertensive crisis brought about by the ingestion of foods rich in tyramine and tryptophan while the client is taking monoamine oxidase inhibitors (MAOIs). These medications act by decreasing the amount of monoamine oxidase in the liver, which is necessary for the breakdown and use of tyramine and tryptophan.
|
|